General Electric has sold the last of its stock in genetics-testing firm NeoGenomics.
The conglomerate’s GE Medical Systems Information Technologies sold 10.8 million NeoGenomics shares for $130 million, a price of $12 each
https://www.barrons.com/articles/ge-sells-98-million-in-pivotal-software-stock-51544807799
2010:
https://www.genomeweb.com/dxpgx/ge-healthcare-acquire-clarient-580m#.XBxfvc9KgWo
2015:
https://www.genengnews.com/topics/translational-medicine/neogenomics-buys-clarient-from-ge-healthcare-for-up-to-275m/
2018: $130M?
Good job, CAS grads who ran (ruined) the company! *slow clap
So desparate most of the Office Admins in Greenville were let go. REALLY?
got to pay for the year end parties and TS's bears games
Should not have bought baker then.
yes GE has nearly $100B in net liabilities and needs about $40B in cash over the next year as there are $8B of corporate debt to pay down in early 2019 and nearly $23B in 2020.